.
.stephen silberstein, md, director, jefferson university headache center..
.
but shocking figures uncovered by labour yesterday show some patients are suffering agonising waits of as many as 541 days to begin treatment..
orchid pharma faces liquidation as lenders reject resolution plan
.
it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done..![]()
.